Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial

• Main Authors: Hua Qu (Author), A-ling Shen (Author), Kuo Yang (Author), Ming-yan Huang (Author), Hong-zheng Li (Author), Wen-wen Yang (Author), Shu-yue Fan (Author), Ling Tan (Author), Jie Wang (Author), Yu-xuan Peng (Author), Jian-feng Chu (Author), Jun Peng (Author), Chang-geng Fu (Author), Lin-zi Long (Author), Ke-ji Chen (Author)
• Format: Book
• Published: Elsevier, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The efficacy and safety of Qingda granule (QDG) in managing blood pressure (BP) among grade 1 hypertensive patients with low-moderate risk remain uncertain. Methods: In the randomized, double-blind, double dummy, non-inferiority and multicenter trial, 552 patients with grade 1 hypertensi...